Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 6.65
-0.15 (-2.21%)
Oct 31, 2025, 3:55 PM GMT+1
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 70.61 million as of October 31, 2025. Its market cap has increased by 96.28% in one year.
Market Cap
70.61M
Enterprise Value
82.46M
Revenue
30.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.65
Market Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 70.61M, a decrease of -58.41%. That is a compound annual growth rate of -8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 70.61M | 234.40% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | 74.69M | -64.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |